Join Growin Stock Community!

Cme group inc.CME.US Overview

US StockFinancial Services
(No presentation for CME)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

CME AI Insights

CME Overall Performance

CME AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

CME Recent Performance

1.57%

Cme group inc.

1.79%

Avg of Sector

-0.31%

S&P500

CME PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

CME Key Information

CME Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

CME Profile

CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products. The company also provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges; and trade processing and risk mitigation services. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. CME Group Inc. was founded in 1898 and is headquartered in Chicago, Illinois.

Price of CME

CME FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

CME Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
11.18
PE Ratio (TTM)
28.65
Forward PE
29.16
PS Ratio (TTM)
17.62
PB Ratio
3.96
Price-to-FCF
27.82
METRIC
VALUE
vs. INDUSTRY
Gross Margin
100.00%
Net Margin
61.67%
Revenue Growth (YoY)
6.37%
Profit Growth (YoY)
6.37%
3-Year Revenue Growth
10.93%
3-Year Profit Growth
10.93%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
11.18
PE Ratio (TTM)
28.65
Forward PE
29.16
PS Ratio (TTM)
17.62
PB Ratio
3.96
Price-to-FCF
27.82
Gross Margin
100.00%
Net Margin
61.67%
Revenue Growth (YoY)
6.37%
Profit Growth (YoY)
6.37%
3-Year Revenue Growth
10.93%
3-Year Profit Growth
10.93%
  • When is CME's latest earnings report released?

    The most recent financial report for Cme group inc. (CME) covers the period of 2025Q4 and was published on 2025/12/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating CME's short-term business performance and financial health. For the latest updates on CME's earnings releases, visit this page regularly.

  • Where does CME fall in the P/E River chart?

    According to historical valuation range analysis, Cme group inc. (CME)'s current price-to-earnings (P/E) ratio is 28.22, placing it in the Watch zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning optimistic. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.

  • What is the operating profit of CME?

    According to the latest financial report, Cme group inc. (CME) reported an Operating Profit of 1.02B with an Operating Margin of 61.84% this period, representing a growth of 7.65% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is CME's revenue growth?

    In the latest financial report, Cme group inc. (CME) announced revenue of 1.65B, with a Year-Over-Year growth rate of 8.09%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much debt does CME have?

    As of the end of the reporting period, Cme group inc. (CME) had total debt of 163.08B, with a debt ratio of 0.82. Short-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.

  • How much cash does CME have?

    At the end of the period, Cme group inc. (CME) held Total Cash and Cash Equivalents of 4.42B, accounting for 0.02 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does CME go with three margins increasing?

    In the latest report, Cme group inc. (CME) achieved the “three margins increasing” benchmark, with a gross margin of 100%%, operating margin of 61.84%%, and net margin of 70.8%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess CME's profit trajectory and future growth potential.

  • Is CME's EPS continuing to grow?

    According to the past four quarterly reports, Cme group inc. (CME)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at 3.25. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of CME?

    Cme group inc. (CME)'s Free Cash Flow (FCF) for the period is 1.1B, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 11.06% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.

  • What are the PEG ratio and PE ratio of CME?

    The latest valuation data shows Cme group inc. (CME) has a Price-To-Earnings (PE) ratio of 28.22 and a Price/Earnings-To-Growth (PEG) ratio of 0.69. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.